Skip to main content

Advertisement

SpringerLink
Log in

Flow cytometric analysis of DNA content in colorectal carcinoma

  • Current Status
  • Published:
Diseases of the Colon & Rectum

Abstract

Over the past decade, flow cytometric DNA analysis has been employed by a number of investigators in an attempt to further define patient prognosis beyond classic pathologic staging. The results of these studies taken independently have been confusing; however, their cumulative effect suggests that flow cytometry is a useful prognostic indicator and can be used to further delineate prognosis within a specific pathologic stage. DNA nondiploid tumors are more likely to recur than diploid tumors, and patients with DNA nondiploid tumors have a poorer five-year survival than patients with DNA diploid tumors. There appears to be a weak relationship between advanced pathologic stage and DNA aneuploid tumors, although there is no clear and consistent relationship between tumor ploidy and histology. Therefore, all patients with colorectal tumors should undergo DNA ploidy analysis. Patients with DNA nondiploid tumors should be treated for biologically more aggressive disease independent of other prognostic variables. Ploidy status should be employed as a variable by which to randomize patients to both primary treatment schemes and adjuvant therapies in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fisher B, Wolmark N, Rockette H,et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP Protocol R-01. J Natl Cancer Inst 1988;80:21–9.

    Google Scholar 

  2. Valone F, Friedman M, Wittlinger P,et al. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or segmental methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group. J Clin Oncol 1989;7:1427–36.

    Google Scholar 

  3. Laurie J, Moertel C, Fleming T,et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 1989;7:1447–56.

    Google Scholar 

  4. Lockhart-Mummery JP. Two hundred cases of cancer of the rectum treated by perineal excision. Br J Surg 1926;14:110–13.

    Google Scholar 

  5. Dukes CE. The spread of cancer of the rectum. Br J Surg 1929;17:643–5.

    Google Scholar 

  6. Gabriel WB, Dukes CE, Bussey HJR. Lymphatic spread of cancer of the rectum. Br J Surg 1935;23:395–409.

    Google Scholar 

  7. Jass JR. Prognostic factors in colorectal cancer. Curr Top Pathol 1990;81:295–322.

    Google Scholar 

  8. Shapiro HM. Flow cytometry of DNA content and other indicators of proliferative activity. Arch Pathol Lab Med 1989;113:591–7.

    Google Scholar 

  9. Barlogie B, Raber M, Schumann J,et al. Flow cytometry in clinical cancer research. Cancer Res 1983;43:3982–97.

    Google Scholar 

  10. Seckinger D, Sugarbaker E, Frankfurt O. DNA content in human cancer. Arch Pathol Lab Med 1989;113:619–26.

    Google Scholar 

  11. Wolley RC, Schreiber K, Koss LG, Larns M, Sherman A. DNA distribution in human colon carcinomas and its relationship to clinical behavior. J Natl Cancer Inst 1982;69:15–22.

    Google Scholar 

  12. Rognum TO, Thorad E, Elgjo K, Brandtzaeg P, Orjasaeter H, Nygaard K. Large-bowel carcinomas with different ploidy, related to secretory component, IgA, and CEA in epithelium and plasma. Br J Cancer 1982;45:921–34.

    Google Scholar 

  13. Armitage NC, Robins RA, Evans DF, Turner DR, Baldwin RW, Hardcastle JD. The influence of tumor cell DNA abnormalities on survival in colorectal cancer. Br J Surg 1985;72:828–30.

    Google Scholar 

  14. Banner B, Tomas-Dela Vega J, Roseman D, Coon J. Should flow cytometric DNA analysis precede definitive surgery for colon carcinoma? Ann Surg 1985;202:740–4.

    Google Scholar 

  15. Durrant L, Robins RA, Armitage N, Brown A, Baldwin R, Hardcastle J. Association of antigen expression and DNA ploidy in human colorectal tumors. Cancer Res 1986;46:3543–9.

    Google Scholar 

  16. Finan PJ, Quirke P, Dixon MF, Dyson JED, Giles GR, Bird CC. Is DNA aneuploidy a good prognostic mediator in patients with advanced colorectal cancer? Br J Cancer 1986;54:327–30.

    Google Scholar 

  17. Goh HS, Jass JR. DNA content and the adenomacarcinoma sequence in the colorectum. J Clin Pathol 1986;39:387–92.

    Google Scholar 

  18. Kokal W, Sheibani K, Terz J, Harada R. Tumor DNA content in the prognosis of colorectal carcinoma. JAMA 1986;255:3123–7.

    Google Scholar 

  19. Melamed MR, Enker W, Banner P, Janov A, Kessler G, Darzynkiewicz Z. Flow cytometry of colorectal carcinoma with three-year follow-up. Dis Colon Rectum 1986;29:184–6.

    Google Scholar 

  20. Teodori L, Tirndelli-Danesi D, Cordelli E,et al. Potential prognostic significance of cytometrically determined DNA abnormality in GI tract human tumors. Ann N Y Acad Sci 1986;468:291–301.

    Google Scholar 

  21. Crissman JD, Zarbo RJ, Ma CK, Niebylski CD. DNA histogram assessment in fresh and paraffin retrieved Dukes B right colon carcinoma: a study of comparative techniques and prognostic implications. Proc Am Assoc Cancer Res 1987;28:771.

    Google Scholar 

  22. Emdin SO, Stenling R, Roos G. Prognostic value of DNA content in colorectal carcinoma: a flow cytometric study with some methodologic aspects. Cancer 1987;60:1282–7.

    Google Scholar 

  23. Quirke P, Dixon MF, Clayden A,et al. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol 1987;151:285–91.

    Google Scholar 

  24. Schutte B, Reynders MMJ, Wiggers T,et al. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res 1987;47:5494–96.

    Google Scholar 

  25. Scott NA, Wiegand HS, Moertel CG, Cha SS, Beart RW, Lieber MM. Colorectal cancer: Dukes stage, tumor site, pre-operative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg 1987;122:1375–9.

    Google Scholar 

  26. Scott NA, Rainwater LM, Wiegand HS,et al. The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma. Dis Colon Rectum 1987;30:513–20.

    Google Scholar 

  27. Scott NA, Grande JP, Weiland LH, Pemberton JH, Beart RW, Lieber MM. Flow cytometric DNA patterns from colorectal cancers—how reproducible are they? Mayo Clin Proc 1987;62:331–7.

    Google Scholar 

  28. Jones DJ, Moore M, Schofield PF. Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study. Br J Surg 1988;75:28–33.

    Google Scholar 

  29. Fischer ER, Siderits RH, Sass R, Risher B. Value of assessment of ploidy in rectal cancers. Arch Pathol Lab Med 1989;113:525–8.

    Google Scholar 

  30. Kokal WA, Gardine RL, Sheibani K,et al. Tumor DNA content in resectable primary colorectal carcinoma. Ann Surg 1989;209:188–93.

    Google Scholar 

  31. Moran K, Cooke T, Forster G,et al. Prognostic value of nucleolar organizer regions and ploidy values in advanced colorectal cancer. Br J Surg 1989;76:1152–5.

    Google Scholar 

  32. Giaretti W, Santi L. Tumor progression by DNA flow cytometry in human colorectal cancer. Int J Cancer 1990;45:597–603.

    Google Scholar 

  33. Hood DL, Petras RE, Edinger M, Fazio V, Tubbs R. Deoxyribonucleic acid ploidy and cell cycle analysis of colorectal carcinoma by flow cytometry. Am J Clin Pathol 1990;93:615–20.

    Google Scholar 

  34. Remvikos Y, Laurent-Purg P, Salmon RJ, Frelat G, Dutrillaux B, Thomas G. Simultaneous monitoring of P53 protein and DNA content of colorectal adenocarcinomas by flow cytometry. Int J Cancer 1990;45:450–6.

    Google Scholar 

  35. Albe X, Vassilakos P, Helfer-Guarnori K,et al. Independent prognostic value of ploidy in colorectal cancer. Cancer 1990;66:1168–75.

    Google Scholar 

  36. Remvikos Y, Muleris M, Vieth P, Salmon RJ, Dutrillaux B. DNA content and genetic evolution of human colorectal adenocarcinoma. A study by flow cytometry and cytogenetic analysis. Int J Cancer 1988;42:539–43.

    Google Scholar 

  37. Enker WE. Flow cytometric determination of tumor cell DNA content and proliferative index as prognostic variables in colorectal cancer. Perspect Colon Rectal Surg 1990;3:1–28.

    Google Scholar 

  38. Traganos F. Flow cytometry: principles and application. Cancer Invest 1984;2:149–63.

    Google Scholar 

  39. Hart I, Fidler I. The implications of tumor heterogenicity for studies on the biology and therapy of cancer metastasis. Biochim Biophys Acta 1981;651:37–50.

    Google Scholar 

  40. Rube CL, Valet G, Eder M. Cellular DNA content and metastasis pattern in colorectal carcinomas. Dirch Arch A Pathol Anat 1988;413:419–24.

    Google Scholar 

  41. Rognum TO, Brandtzaeg P, Thorad E. Is heterogenous expression of HLA-DR antigens and CEA along with DNA-profile variations evidence of phenolytic instability and clonal proliferation in human largebowel carcinomas? Br J Cancer 1983;48:543–51.

    Google Scholar 

  42. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333–5.

    Google Scholar 

  43. Crissman JD, Zarbo RJ, Ma CK, Visscher D. Histopathologic parameters and DNA analysis in colorectal adenocarcinomas. Virchows Arch [A] 1989;24:103–47.

    Google Scholar 

  44. Shackney SE, Smith CA, Miller BW,et al. Model for the genetic evolution of human solid tumors. Cancer Res 1989;49:3344–54.

    Google Scholar 

  45. Bauer KD, Lincoln ST, Vera-Roman JM,et al. Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinoma. Lab Invest 1987;57:329–35.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Section of Colon and Rectal Surgery, St. Louis University Medical Center, St. Louis, Missouri

    Phillip A. Dean M.D. & Anthony M. Vernava III M.D.

Authors
  1. Phillip A. Dean M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony M. Vernava III M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Dean, P.A., Vernava, A.M. Flow cytometric analysis of DNA content in colorectal carcinoma. Dis Colon Rectum 35, 95–102 (1992). https://doi.org/10.1007/BF02053349

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02053349

Key words

Search

Navigation